Discusses how Pharmacy Benefits Managers impact drug formulary decisions, patient cost sharing, utilization management, and pharmacy access.
Impact of PBM practices on patients
read more
Copay Accumulators, State Bans & IRS Issues
HIV+Hep’s Carl Schmid’s presentation before the NAIC Regulatory Framework Task Force on the value of copay assistance for Rx, state laws that ensure copay assistance counts, and ways to mitigate any potential conflicts with those state laws with IRS/Health Savings Account issues.
Policies and programs needed to ensure PrEP access nationwide
Details the policies and programs needed to overcome barriers to #PrEP access, including funding a national PrEP program with grants for community and provider outreach, coverage of associated services, and enforcing no-cost-sharing rules
From evidence to implementation: clarifications around USPSTF recommendations for HIV pre-exposure prophylaxis (PrEP) – episode 17: Key takeaways for the management of HIV PrEP
A panel of experts, including HIV+Hep’s Carl Schmid, shares thoughts and advice for the management and uptake of HIV PrEP therapy.
From evidence to implementation: Clarifications around USPSTF recommendations for HIV pre-exposure prophylaxis (PrEP) – episode 16 Overcoming HIV PrEP access barriers with advocacy groups
Carl Schmid shares insight on the use of advocacy groups to help patients overcome barriers to access for HIV PrEP therapy.